Just-approved flu vaccine uses newer production method

Just-approved flu vaccine uses newer production method

(HealthDay)—Flucelvax is the first seasonal flu vaccine to be approved by the U.S. Food and Drug Administration using a manufacturing method called cell culture technology, the agency said.

Other flu vaccines are produced inside eggs. But that process takes longer than the newer method and could be harmful to people with egg allergies, the FDA explained. In cell culture technology, are grown inside mammalian .

This technology has been used for decades to produce other vaccines, the agency said, and since it is quicker, it can be used more efficiently to develop flu vaccines rapidly in the event of a pandemic.

Flucelvax was evaluated in clinical studies in the United States and Europe involving some 7,700 people ages 18 to 49. Common side effects included pain, redness, injection-site soreness, headache, and fatigue—reactions typically seen in people given egg-based flu vaccines, the FDA said.

The U.S. Centers for Disease Control and Prevention recommends the annual for anyone 6 months and older.

Flucelvax is produced by Novartis Vaccines and Diagnostics, based in Marburg, Germany.

More information: More Information

add to favorites email to friend print save as pdf

Related Stories

FDA approves flu vaccine for coming season

Aug 14, 2012

(HealthDay) -- The formulation for the vaccine that will help protect against the flu this coming season was approved by the U.S. Food and Drug Administration on Monday.

Cell-based flu shot beats current vaccine: study

Feb 15, 2011

Flu vaccines made from lab-grown cells work at least as well as those derived from viruses cultivated in chicken eggs, the preferred method for 50 years, according to a study released Wednesday.

New development could increase flu vaccine supply

Jun 02, 2011

(Medical Xpress) -- Scientists from the U.S. Food and Drug Administration and the pharmaceutical company Novartis announced today in the journal Science Translational Medicine that they have developed a new adjuvant, or com ...

Germany orders recall of some Novartis flu shots

Oct 25, 2012

(AP)—German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.

Recommended for you

Added benefit of vedolizumab is not proven

5 hours ago

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments